APA

Soos J. M., Krieger J. I., Stüve O., King C. L., Patarroyo J. C., Aldape K., Wosik K., Slavin A. J., Nelson P. A., Antel J. P. & Zamvil S. S. (20020122). Malignant glioma cells use MHC class II transactivator (CIITA) promoters III and IV to direct IFN-gamma-inducible CIITA expression and can function as nonprofessional antigen presenting cells in endocytic processing and CD4(+) T-cell activation. : Glia.

Chicago

Soos J M, Krieger J I, Stüve O, King C L, Patarroyo J C, Aldape K, Wosik K, Slavin A J, Nelson P A, Antel J P and Zamvil S S. 20020122. Malignant glioma cells use MHC class II transactivator (CIITA) promoters III and IV to direct IFN-gamma-inducible CIITA expression and can function as nonprofessional antigen presenting cells in endocytic processing and CD4(+) T-cell activation. : Glia.

Harvard

Soos J. M., Krieger J. I., Stüve O., King C. L., Patarroyo J. C., Aldape K., Wosik K., Slavin A. J., Nelson P. A., Antel J. P. and Zamvil S. S. (20020122). Malignant glioma cells use MHC class II transactivator (CIITA) promoters III and IV to direct IFN-gamma-inducible CIITA expression and can function as nonprofessional antigen presenting cells in endocytic processing and CD4(+) T-cell activation. : Glia.

MLA

Soos J M, Krieger J I, Stüve O, King C L, Patarroyo J C, Aldape K, Wosik K, Slavin A J, Nelson P A, Antel J P and Zamvil S S. Malignant glioma cells use MHC class II transactivator (CIITA) promoters III and IV to direct IFN-gamma-inducible CIITA expression and can function as nonprofessional antigen presenting cells in endocytic processing and CD4(+) T-cell activation. : Glia. 20020122.